Brian Douglass serves as Senior Vice President and Chief Product Officer at Repligen Corporation, a global leader in bioprocessing technologies and solutions for biologic drug manufacturing. In this pivotal role, he leads the company's product strategy, portfolio management, and innovation roadmap, overseeing a diverse range of products including filtration systems, chromatography resins, and process analytics tools. Brian ensures that Repligen's offerings align with evolving customer needs in the biopharmaceutical industry, driving commercialization efforts that accelerate the development and scale-up of biologics, cell and gene therapies, and mRNA vaccines. With more than 25 years of experience in bioprocessing and life sciences, Brian joined Repligen in 2021 as Senior Vice President and General Manager of the Process Analytics business before advancing to his current position. His career includes senior leadership roles at GE Healthcare Life Sciences, where he spearheaded product management for single-use technologies and bioprocess consumables, and at Pall Corporation (now part of Cytiva), focusing on filtration and purification solutions. Earlier, at Millipore Corporation, he built expertise in bioprocess engineering, contributing to groundbreaking advancements in membrane technology. Under Brian's guidance, Repligen has achieved significant milestones, including the successful launch of next-generation C FLEX® connector systems and expansions in the OPUS® chromatography column portfolio, which have enhanced manufacturing efficiency and scalability for clients worldwide. His strategic vision has fueled double-digit growth in key product lines, strengthened partnerships with major biopharma companies, and positioned Repligen at the forefront of sustainable bioprocessing innovations.